Meet NovAliX at RICT in Bordeaux, France, from July 3 to 5, 2024. The 58th International Conference on Medicinal Chemistry is organized by The French Medicinal Chemistry Society (Société de Chimie Thérapeutique – SCT).
The conference will focus on “Interfacing chemical biology and drug discovery” with a range of scientific topics, including 18 plenary lectures and 6 short lectures.
Great speakers from academia such as Prof. Alesso Ciulli from University of Dundee (UK) with his talk on “How PROTAC degraders work: molecular recognition and design principles” are expected.
Prof. Gregory L.Verdine, President of Lifemine Therapeutics (USA), will give the inaugural lecture on “Toward universal druggability”.
The sessions will focus on, to quote only them:
- RNA binding molecules
- Breakthoughs in deep learning, Cryo-EM
- New modalities for drug discovery
- Recent trends in neurodegenerative diseases drug development
- Next generation cancer therapeutics
- First disclosures of clinical candidates and cases studies
- Enabling technologies
Come and discuss your scientific projects with our NovAliX Business Development and scientific team at our booth no.27 at RICT 2024, in the ‘Palais des Congrès’ in Bordeaux:
Anne de Villeroché, PhD, Associate Director Business Development
Anne Pecquery, Director Business Development, Drug Discovery and Pharmacology
Taouès Temal-Laib, PhD, Senior Research Fellow, Director Drug Discovery
Event
Visit websiteDate
From
Jul 04, 2024
to
Jul 05, 2024
Location
Bordeaux, France
Attendees
Anne de Villeroché, PhD
Associate Director Business Development
Anne Pecquery
Director Business Development, Drug Discovery and Pharmacology
Taouès Temal-Laib, PhD
Senior Research Fellow, Director Drug Discovery